Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Recruiting · NCT05221021 · Registry updated 2024-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome | Overactive Bladder Syndrome | Recruiting | Phase 4 | 2024-08-19 | NCT05221021 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Walter Reed National Military Medical Center | 40 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Walter Reed National Military Medical Center | Bethesda | United States | 36 |